BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 1, 2026
See today's BioWorld MedTech
Home
» Olympus co-launches Swan as new JV for endoluminal GI robotics
To read the full story,
subscribe
or
sign in
.
Olympus co-launches Swan as new JV for endoluminal GI robotics
Aug. 5, 2025
By
Marian (YoonJee) Chu
Olympus Corp.’s “active investment” in endoluminal robotics has materialized in a new joint venture med-tech called Swan Endosurgical Inc., with Revival Healthcare Capital LLC.
Deals and M&A
Medical technology
Newco news
Regulatory
Robotic surgery
U.S.
510(k)
FDA